drugset / Trial / NCT03548493

Magnesium Sulphate Versus Fentanyl for Conscious Sedation in CSDH

NCT03548493

Phase 2 Completed 34 enrolled Kasr El Aini Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators hypothesize that magnesium sulphate owing to its analgesic and sedative properties is not inferior to fentanyl in providing conscious sedation as adjuvants to propofol and local injection of lidocaine in patients undergoing surgery for evacuation of subdural haematoma. Consequently, the investigators are testing this hypothesis by comparing the sedative and analgesic effects of magnesium sulphate versus fentanyl as adjuvants to propofol lidocaine admixture for conscious sedation in patients undergoing burr hole surgery for evacuation of subdural haematoma.

Timeline

Start
2018-04-10
Primary completion
2018-08-08
Completion
2018-08-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 0.5 ug/kg Intravenous
Subject Magnesium Sulfate Other / unclassified 15 mg/kg Intravenous
Background Propofol Small molecule 20 ug/kg Intravenous
Background Propofol Small molecule 40 ug/kg Intravenous

Indications

No indication recorded.